Jane Street Group, LLC Rigel Pharmaceuticals Inc Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$1.12 - $1.57 $5,061 - $7,094	-4,519 Reduced 8.9%	46,254 $68,000
Q4 2023 Feb 14, 2024	BUY	$0.72 - $1.56 $19,230 - $41,666	26,709 Added 110.99%	50,773 $73,000
Q3 2023 Nov 14, 2023	SELL	$1.07 - $1.39 $45,522 - $59,136	-42,544 Reduced 63.87%	24,064 $25,000
Q2 2023 Aug 14, 2023	SELL	$1.12 - $1.82 $69,882 - $113,558	-62,395 Reduced 48.37%	66,608 $85,000
Q1 2023 May 15, 2023	BUY	$1.25 - $2.0 $29,420 - $47,072	23,536 Added 22.32%	129,003 $170,000
Q4 2022 Feb 14, 2023	SELL	$0.67 - $11.9 $91,841 - $1.63 Million	-137,077 Reduced 56.52%	105,467 $158,000
Q3 2022 Nov 14, 2022	BUY	$1.1 - $12.2 $187,760 - $2.08 Million	170,691 Added 237.56%	242,544 $286,000
Q3 2022 Nov 14, 2022	BUY	$1.1 - $12.2 $187,760 - $2.08 Million	170,691 Added 237.56%	242,544 $286,000
Q2 2022 Aug 16, 2022	BUY	$0.67 - $3.19 $9,270 - $44,140	13,837 Added 23.85%	71,853 $81,000
Q1 2022 May 17, 2022	SELL	$2.22 - $3.45 $56,019 - $87,057	-25,234 Reduced 30.31%	58,016 $173,000
Q4 2021 Feb 15, 2022	SELL	$2.36 - $3.57 $15,762 - $23,844	-6,679 Reduced 7.43%	83,250 $220,000
Q3 2021 Nov 16, 2021	SELL	$3.5 - $4.5 $82,967 - $106,672	-23,705 Reduced 20.86%	89,929 $326,000
Q2 2021 Aug 16, 2021	BUY	$3.09 - $4.54 $306,234 - $449,936	99,105 Added 682.12%	113,634 $493,000
Q1 2021 May 18, 2021	SELL	$3.35 - $4.93 $122,733 - $180,620	-36,637 Reduced 71.6%	14,529 $50,000
Q4 2020 Feb 17, 2021	BUY	$2.35 - $3.74 $47,500 - $75,596	20,213 Added 65.3%	51,166 $179,000
Q3 2020 Nov 17, 2020	SELL	$1.78 - $4.13 $115,765 - $268,602	-65,037 Reduced 67.75%	30,953 $74,000
Q2 2020 Aug 17, 2020	BUY	$1.41 - $2.05 $135,345 - $196,779	95,990 New	95,990 $176,000
Q3 2019 Nov 14, 2019	SELL	$1.63 - $2.62 $126,422 - $203,207	-77,560 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$2.02 - $2.61 $130,168 - $168,188	64,440 Added 491.16%	77,560 $202,000
Q1 2019 May 16, 2019	BUY	$2.0 - $2.65 $26,240 - $34,768	13,120 New	13,120 $34,000
Q1 2018 May 15, 2018	SELL	$3.54 - $4.54 $132,459 - $169,877	-37,418 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$3.23 - $4.3 $39,964 - $53,203	12,373 Added 49.4%	37,418 $145,000
Q3 2017 Nov 14, 2017	BUY	$2.18 - $2.57 $54,598 - $64,365	25,045	25,045 $64,000

Others Institutions Holding RIGL

# of Institutions

Shares Held

334K

Call Options Held

Put Options Held

View Full List

About RIGEL PHARMACEUTICALS INC

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.96B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

More about RIGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account